| TNNI3K (HH498) | MLK | TKL | 4yff | B | B | 3-[(5-bromo-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6063 | 1.00 | |
| TNNI3K (HH498) | MLK | TKL | 4yfi | D | A | n-methyl-3-(9h-purin-6-ylamino)benzenesulfonamide | Human | 6072 | 0.41 | |
| TNNI3K (HH498) | MLK | TKL | 4yfi | C | A | n-methyl-3-(9h-purin-6-ylamino)benzenesulfonamide | Human | 6070 | 0.41 | |
| TNNI3K (HH498) | MLK | TKL | 4yff | C | B | 3-[(5-bromo-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6067 | 1.00 | |
| TNNI3K (HH498) | MLK | TKL | 4yfi | D | B | n-methyl-3-(9h-purin-6-ylamino)benzenesulfonamide | Human | 6064 | 0.41 | |
| TNNI3K (HH498) | MLK | TKL | 4yff | C | A | 3-[(5-bromo-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6069 | 1.00 | |
| TNNI3K (HH498) | MLK | TKL | 4yff | A | A | 3-[(5-bromo-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6068 | 1.00 | |
| TNNI3K (HH498) | MLK | TKL | 4yff | D | B | 3-[(5-bromo-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6074 | 1.00 | |
| TNNI3K (HH498) | MLK | TKL | 4yfi | C | B | n-methyl-3-(9h-purin-6-ylamino)benzenesulfonamide | Human | 6073 | 0.41 | |
| TNNI3K (HH498) | MLK | TKL | 4yfi | A | B | n-methyl-3-(9h-purin-6-ylamino)benzenesulfonamide | Human | 6071 | 0.41 | |
| TNNI3K (HH498) | MLK | TKL | 4yff | D | A | 3-[(5-bromo-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6066 | 1.00 | |
| TNNI3K (HH498) | MLK | TKL | 4yfi | A | A | n-methyl-3-(9h-purin-6-ylamino)benzenesulfonamide | Human | 6059 | 0.41 | |
| TNNI3K (HH498) | MLK | TKL | 4yff | B | A | 3-[(5-bromo-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6065 | 1.00 | |
| TNNI3K (HH498) | MLK | TKL | 4yfi | B | A | n-methyl-3-(9h-purin-6-ylamino)benzenesulfonamide | Human | 6061 | 0.41 | |
| TNNI3K (HH498) | MLK | TKL | 4yff | A | B | 3-[(5-bromo-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6062 | 1.00 | |
| TNNI3K (HH498) | MLK | TKL | 4yfi | B | B | n-methyl-3-(9h-purin-6-ylamino)benzenesulfonamide | Human | 6060 | 0.41 | |
| STK4 (MST1) | STE20 | STE | 6yat | B | | 4-[5-(3-chlorophenyl)-7~{h}-pyrrolo[2,3-d]pyrimidin-4-yl]morpholine | Human | 12242 | 0.44 | |
| STK4 (MST1) | STE20 | STE | 6yat | A | | 4-[5-(3-chlorophenyl)-7~{h}-pyrrolo[2,3-d]pyrimidin-4-yl]morpholine | Human | 12241 | 0.44 | |
| STK24 (MST3) | STE20 | STE | 4u8z | A | | 3-[4-(morpholin-4-yl)-7h-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile | Human | 5610 | 0.40 | |
| CHEK1 (CHK1) | CAMKL | CAMK | 5op5 | A | | 3-[4-(morpholin-4-yl)-7h-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile | Human | 8600 | 0.40 | |
| BRAF | RAF | TKL | 4yht | B | | 3-[(5-chloro-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6443 | 0.85 | |
| BRAF | RAF | TKL | 4yht | A | | 3-[(5-chloro-7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-n-methyl-4-(morpholin-4-yl)benzenesulfonamide | Human | 6442 | 0.85 | |
